VC-Backed Ra Pharmaceuticals Raises $92M In Upsized IPO
Venture capital-backed biotech company Ra Pharmaceuticals announced Wednesday it has raised $92 million in its initial public offering, within its planned range but with a higher share count than planned....To view the full article, register now.
Already a subscriber? Click here to view full article